Sandip I. Patel - 30 Sep 2021 Form 3 Insider Report for Monterey Bio Acquisition Corp

Role: Director, 10%+ Owner
Signature: /s/ Tricia Branker, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 30 Sep 2021
Net transactions value: $0
Form type: 3
Filing time: 30 Sep 2021, 17:51:53 UTC
Next filing: 13 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MTRY	Common Stock						1,912,500	30 Sep 2021	See footnote	F1, F2
holding	MTRY	Common Stock						35,000	30 Sep 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes up to 281,250 shares subject to forfeiture depending on the extent to which the underwriter's option to purchase additional units is exercised.
F2	The shares are held directly by NorthStar Bio Ventures, LLC (the "NorthStar Co-Sponsor"). NorthStar Co-Sponsor is managed by the Reporting Person. Accordingly, the Reporting Person has voting and dispositive power over the shares held by NorthStar Co-Sponsor and may be deemed to beneficially own such shares. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Content

Includes up to 281,250 shares subject to forfeiture depending on the extent to which the underwriter's option to purchase additional units is exercised.

The shares are held directly by NorthStar Bio Ventures, LLC (the "NorthStar Co-Sponsor"). NorthStar Co-Sponsor is managed by the Reporting Person. Accordingly, the Reporting Person has voting and dispositive power over the shares held by NorthStar Co-Sponsor and may be deemed to beneficially own such shares. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Remarks:

See Exhibit 24.1 - Power of Attorney